CD8A and neoplasm: Intriguingly, NK4 in combination with DC vaccination inhibited the growth of experimental solid tumors, promoted tumor antigen-specific secretion of IFN-γ by CD8+ T cells and elicited MHC class I-restricted CTL activity against the parental tumor cells [67].